Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Human umbilical cord mesenchymal stem cells(Shandong Qilu Stem Cells) in Alzheimer Disease: NCT07208344 Clinical Landscape Report 2026
16 October 2026
NCT07208344 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Daridorexant hydrochloride in Alzheimer Disease: NCT07213349 Clinical Landscape Report 2026
16 October 2026
NCT07213349 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Xanomeline Tartrate/Trospium Chloride in Alzheimer Disease: NCT07212062 Clinical Landscape Report 2026
16 October 2026
NCT07212062 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ALN-5288 in Alzheimer Disease: NCT07214727 Clinical Landscape Report 2026
16 October 2026
NCT07214727 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ARO-MAPT in Alzheimer Disease: NCT07221344 Clinical Landscape Report 2026
16 October 2026
NCT07221344 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tofacitinib Citrate in Colitis, Ulcerative: CTRI/2025/11/097059 Clinical Landscape Report 2026
16 October 2026
CTRI/2025/11/097059 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Balinatunfib in Crohn Disease: NCT07222189 Clinical Landscape Report 2026
16 October 2026
NCT07222189 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Bumetanide analog(NeuroPro Therapeutics, Inc.) in Alzheimer Disease: NCT07222878 Clinical Landscape Report 2026
16 October 2026
NCT07222878 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
N-acetylglucosamine in Crohn Disease: NCT07225998 Clinical Landscape Report 2026
16 October 2026
NCT07225998 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nivolumab in Pancreatic adenocarcinoma metastatic: NCT07226856 Clinical Landscape Report 2026
16 October 2026
NCT07226856 clinical landscape for Pancreatic adenocarcinoma metastatic: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
SapDM275 in Metastatic Pancreatic Cancer: NCT07231094 Clinical Landscape Report 2026
16 October 2026
NCT07231094 clinical landscape for Metastatic Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Troculeucel in Alzheimer Disease: NCT07228078 Clinical Landscape Report 2026
16 October 2026
NCT07228078 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.